IOLCP CEO on future of demand-supply of Ibuprofen ahead

Jul 13, 2021

IOL Pharma & Chemicals CEO on CNBC TV projected good demand ahead of Ibuprofen. Now, PLI scheme is also attractive to the company. It may take part.


IOLCP CEO has said that 

- It generally takes 2 quarters to benefits from a price hike.
- COVID has a negative impact on Ibuprofen due to report from the EU but now everything is clear. No bad impact of Ibuprofen to covid patients.
- I see demand to pickup.

IOL Pharmaceuticals and Chemicals as stock was in downtrend from long time. Now, it looks like it has got it bottom in recent past. Current Market Price is Rs 684.

Whole Interview on CNBC

You Might Also Like

0 Comments

Labels

investment (125) stocks (92) India (85) Society (67) Social Issue (35) Indian Politics (34) Economy (28) Health (25) Business (23) Stock market (22) Bihar (21) Indian Market (21) International (21) fun (20) corruption (17) social (12) Cricket (11) India Security (10) bangalore (10)

Subscribe